About: 5-APDB

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB, 3-Desoxy-MDA, EMA-4) is a putative entactogen drug of the phenethylamine and amphetamine classes. It is an analogue of MDA where the heterocyclic 3-position oxygen from the 3,4-methylenedioxy ring has been replaced by a methylene bridge. 6-APDB is an analogue of 5-APDB where the 4-position oxygen has been replaced by a methylene bridge instead. 5-APDB was developed by a team led by David E. Nichols at Purdue University as part of their research into non-neurotoxic analogues of MDMA.

Property	Value
dbo:abstract	5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB, 3-Desoxy-MDA, EMA-4) is a putative entactogen drug of the phenethylamine and amphetamine classes. It is an analogue of MDA where the heterocyclic 3-position oxygen from the 3,4-methylenedioxy ring has been replaced by a methylene bridge. 6-APDB is an analogue of 5-APDB where the 4-position oxygen has been replaced by a methylene bridge instead. 5-APDB was developed by a team led by David E. Nichols at Purdue University as part of their research into non-neurotoxic analogues of MDMA. In animal studies, 5-APDB's effects generalize most closely to non-stimulant MDMA analogues such as MBDB and MMAI, while producing no substitution for LSD or amphetamine. In vitro studies show that 5-APDB acts as a highly selective serotonin releasing agent (SSRA), with IC50 values of 130 nM, 7,089 nM, and 3,238 nM for inhibiting the reuptake of serotonin, dopamine, and norepinephrine, respectively. In contrast, 6-APDB is more balanced on the three monoamine neurotransmitters and acts more similarly to MDA and MDMA. Methoxy-substituted analogues of 5-APDB and 6-APDB have also been made and substituted for DOM in animal tests, although they were around one tenth as potent as DOM. (en)
dbo:casNumber	152624-03-8
dbo:fdaUniiCode	UI10BAJ8SH
dbo:pubchem	192601
dbo:thumbnail	wiki-commons:Special:FilePath/3-desoxy-MDA.svg?width=300
dbo:wikiPageID	20119063 (xsd:integer)
dbo:wikiPageLength	5826 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1120662770 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Purdue_University dbr:Methylene_bridge dbr:Methylenedioxy dbr:David_E._Nichols dbr:In_vitro dbr:Neurotransmitter dbr:Structural_analog dbr:Substituted_amphetamine dbr:Reuptake_inhibitor dbc:Designer_drugs dbc:Entactogens_and_empathogens dbc:Serotonin_releasing_agents dbr:Monoamine_neurotransmitter dbr:MBDB dbr:MDMA dbr:Functional_group dbr:Stimulant dbr:2,5-Dimethoxy-4-methylamphetamine dbr:Drug dbr:3,4-Methylenedioxyamphetamine dbr:Amphetamine dbc:5-Benzofuranethanamines dbr:Norepinephrine dbc:Substituted_amphetamines dbr:LSD dbr:Binding_selectivity dbr:Dopamine dbr:Entactogen dbr:Neurotoxic dbr:Serotonin dbr:Serotonin_releasing_agent dbr:Substituted_phenethylamine dbr:IC50 dbr:Reuptake dbr:Heterocyclic dbr:Temporary_class_drug dbr:5-Methyl-6-methoxy-2-aminoindane
dbp:atcPrefix	none (en)
dbp:c	11 (xsd:integer)
dbp:casNumber	152624 (xsd:integer)
dbp:chemspiderid	167143 (xsd:integer)
dbp:h	15 (xsd:integer)
dbp:iupacName	1 (xsd:integer)
dbp:legalCa	Schedule I (en)
dbp:legalDe	NpSG (en)
dbp:legalUk	Class B (en)
dbp:n	1 (xsd:integer)
dbp:o	1 (xsd:integer)
dbp:pubchem	192601 (xsd:integer)
dbp:routesOfAdministration	Oral (en)
dbp:smiles	Cl.CCCc1cc2CCOc2cc1 (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	BZKLFXQUBIRXAK-UHFFFAOYSA-N (en)
dbp:unii	UI10BAJ8SH (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	477223997 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Entactogens dbt:Monoamine_releasing_agents dbt:Phenethylamines dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Fdacite dbt:Stdinchicite
dcterms:subject	dbc:Designer_drugs dbc:Entactogens_and_empathogens dbc:Serotonin_releasing_agents dbc:5-Benzofuranethanamines dbc:Substituted_amphetamines
gold:hypernym	dbr:Drug
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatBenzofurans yago:Abstraction100002137 yago:Benzofuran114898101 yago:Chemical114806838 yago:Compound114818238 yago:Material114580897 yago:Matter100020827 yago:Part113809207 yago:PhysicalEntity100001930 yago:Relation100031921 dbo:Drug yago:Substance100019613 umbel-rc:DrugProduct
rdfs:comment	5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB, 3-Desoxy-MDA, EMA-4) is a putative entactogen drug of the phenethylamine and amphetamine classes. It is an analogue of MDA where the heterocyclic 3-position oxygen from the 3,4-methylenedioxy ring has been replaced by a methylene bridge. 6-APDB is an analogue of 5-APDB where the 4-position oxygen has been replaced by a methylene bridge instead. 5-APDB was developed by a team led by David E. Nichols at Purdue University as part of their research into non-neurotoxic analogues of MDMA. (en)
rdfs:label	5-APDB (en)
owl:sameAs	freebase:5-APDB yago-res:5-APDB wikidata:5-APDB dbpedia-sh:5-APDB dbpedia-sr:5-APDB https://global.dbpedia.org/id/4JYi6
prov:wasDerivedFrom	wikipedia-en:5-APDB?oldid=1120662770&ns=0
foaf:depiction	wiki-commons:Special:FilePath/3-desoxy-MDA.svg
foaf:isPrimaryTopicOf	wikipedia-en:5-APDB
is dbo:wikiPageRedirects of	dbr:Ema-4 dbr:5-(2-Aminopropyl)-2,3-dihydrobenzofuran dbr:5-Aminopropyldihydrobenzofuran
is dbo:wikiPageWikiLink of	dbr:List_of_designer_drugs dbr:C11H15NO dbr:List_of_psychedelic_drugs dbr:TAAR1 dbr:6-APDB dbr:5-MAPDB dbr:Substituted_benzofuran dbr:Substituted_methylenedioxyphenethylamine dbr:Temporary_class_drug dbr:Ema-4 dbr:5-(2-Aminopropyl)-2,3-dihydrobenzofuran dbr:5-Aminopropyldihydrobenzofuran
is foaf:primaryTopic of	wikipedia-en:5-APDB

This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License